Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation.

about

Unleashing the immune response against childhood solid cancers.Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor models.

P2860

Q39224315-2BC1DD6E-4EB8-4175-BAAA-5348A05674E4 Q42288675-B5472C6E-070F-4574-BDFE-309AFF06D504

P2860

Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation.

Item

http://www.wikidata.org/entity/Q42177586

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Chemotherapy-induced myeloid s ...... motherapy in immunomodulation.

@en

Chemotherapy-induced myeloid s ...... motherapy in immunomodulation.

@nl

type

Item

label

Chemotherapy-induced myeloid s ...... motherapy in immunomodulation.

@en

Chemotherapy-induced myeloid s ...... motherapy in immunomodulation.

@nl

prefLabel

Chemotherapy-induced myeloid s ...... motherapy in immunomodulation.

@en

Chemotherapy-induced myeloid s ...... motherapy in immunomodulation.

@nl

P1476

Chemotherapy-induced myeloid s ...... motherapy in immunomodulation.

@en

P2093

David H Munn

http://www.w3.org/2001/XMLSchema#string

Gang Zhou

http://www.w3.org/2001/XMLSchema#string

Zhi-Chun Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice

Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy.

Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma.

Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.

Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.

Characterization of cyclophosphamide-induced suppressor cells.

P304

e954471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/21624011.2014.954471

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273956356

http://www.w3.org/2001/XMLSchema#string

P698

25610747

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

4292425

http://www.w3.org/2001/XMLSchema#string

Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation.

about

P2860

P2860

Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932